Postmenopausal estrogen therapy and cardiovascular disease

Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women.

The Journal of clinical endocrinology and metabolism·2001

Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people.

Journal of the American Geriatrics Society·2001

Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue.

Endocrine·2001

Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.

Arteriosclerosis, thrombosis, and vascular biology·2000